Archana Kapoor | Pharmaceutical | Best Researcher Award

Prof. Archana Kapoor | Pharmaceutical | Best Researcher Award

Guru Jambheshwar University of Science & Technology-India

Author Profile

Early Academic Pursuits 📚

Born on October 25, 1978, Archana Kapoor embarked on her academic journey with a passion for pharmaceutical sciences. She pursued her undergraduate and postgraduate studies in Pharmaceutical Chemistry at Punjab University, Chandigarh, one of India’s premier institutions. Earning her post-graduation in 2003, she honed her expertise in drug discovery, medicinal chemistry, and pharmacokinetics. Her strong foundation in chemistry and pharmaceutical sciences earned her a GATE scholarship, a prestigious recognition of her academic excellence. Archana further enhanced her academic credentials by completing her Doctorate in Pharmaceutical Sciences from Guru Jambheshwar University of Science & Technology in 2016, marking a significant milestone in her pursuit of scientific knowledge and innovation.

Professional Endeavors đŸ‘©â€đŸ”Ź

With almost 18 years of experience, Archana Kapoor’s career reflects her dedication to bridging the gap between academic research and industrial application. She commenced her professional journey in 2006 by joining Dr. Reddy’s Laboratories, Hyderabad, as a Scientist in the Discovery Chemistry section. During her tenure at Dr. Reddy’s, she gained invaluable experience in drug metabolism, pharmacokinetics, and advanced bioanalytical techniques such as HPLC and LC-MS/MS. Her work in the AMPK kinase project focused on developing lead series for Type-II Diabetes, contributing to the global efforts in combating this widespread condition.In 2016, Archana transitioned into academia, where she now serves as a Professor in the Department of Pharmaceutical Sciences at Guru Jambheshwar University of Science & Technology. Here, she plays a pivotal role in teaching, mentoring students, and spearheading research initiatives. Her ability to integrate real-world experience with academic learning has made her a respected figure among her peers and students alike.

Contributions and Research Focus 🔬

Archana Kapoor’s research portfolio is a testament to her deep commitment to advancing pharmaceutical sciences. Her work spans drug discovery, molecular docking, and pharmacokinetic analysis. One of her most significant contributions is her research on “5-Nitro-N-phenyl-3-(phenylamino)-1H-indazole-1-carboxamide Derivatives as Potential Anticancer Agents.” This study integrates chemical synthesis, in silico docking, and molecular dynamics simulations to explore new anticancer agents. The innovation in this research lies in its multi-faceted approach, targeting not just the synthesis of compounds but also analyzing their molecular interactions to optimize their efficacy as anticancer drugs.Her contributions to the discovery and development of new therapeutic agents extend beyond cancer treatment. While working at Dr. Reddy’s, Archana played a crucial role in the R&D sector, contributing to key projects that focused on metabolic disorders like Type-II Diabetes. Her experience with leading pharmaceutical companies and her academic background allows her to bring a comprehensive perspective to the challenges in drug discovery.

Innovations in Pharmaceutical Sciences 💡

Archana has consistently leveraged cutting-edge technology in her research, particularly in the integration of computational methods with experimental data. Her use of in silico techniques for drug discovery, including molecular docking and simulations, has streamlined the identification of promising drug candidates, saving both time and resources. By combining computational approaches with traditional experimental methods, Archana’s research has opened new avenues for discovering efficient and targeted therapeutic solutions.Her innovative methodologies reflect her forward-thinking approach and her drive to push the boundaries of pharmaceutical research. This integration of technology into drug discovery processes ensures that her work not only meets current scientific standards but also sets the stage for future advancements in the field.

Accolades and Recognition 🏆

Throughout her career, Archana Kapoor has been recognized for her exceptional contributions to pharmaceutical sciences. She has been the recipient of several awards and honors, including a prestigious Award of Honour for her exemplary efforts in education and research. Her research publications in renowned scientific journals and her presentations at international conferences have further solidified her standing as a leader in her field.Her work has also earned her recognition within the scientific community for her research on novel anticancer agents. The synthesis and analysis of new chemical compounds that can potentially contribute to cancer treatment has positioned her as an influential voice in pharmaceutical research. Additionally, her GATE scholarship during her postgraduate studies underscores her academic brilliance and commitment to excellence.

Impact and Influence 🌍

Archana Kapoor’s impact extends beyond her own research; she has become a mentor and a guide for the next generation of pharmaceutical scientists. As a professor, she has not only imparted knowledge but has also encouraged her students to engage in innovative thinking and research. Her leadership in various academic and research initiatives at Guru Jambheshwar University has led to the establishment of strong research networks and collaborations, fostering a culture of inquiry and innovation.Her participation in seminars, workshops, and conferences has further contributed to knowledge dissemination and professional networking. She has been instrumental in organizing academic events that bring together experts from various fields to discuss advancements in pharmaceutical sciences. Through these efforts, Archana has become a key figure in the pharmaceutical academic community, influencing both her peers and her students.

Legacy and Future Contributions đŸŒ±

Looking ahead, Archana Kapoor is committed to continuing her research in drug discovery, with a specific focus on developing new therapeutic agents for cancer and metabolic diseases. Her interdisciplinary approach, combining chemistry, pharmacology, and computational methods, promises to drive future innovations in pharmaceutical research.In addition to her research contributions, Archana aims to continue her mentorship role, guiding young scientists and researchers in their academic and professional journeys. Her legacy is not only defined by her own research achievements but also by the impact she has had on shaping the future of pharmaceutical sciences through her students.

Citations

A total of 208 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         208
  • h-index           8
  • i10-index        6

Notable Publications 

  • Exploration of N‐(6‐Indazolyl) Benzenesulfonamide Derivatives as Potential Antioxidants and Antimicrobial Agents: Integrating Synthesis, In Silico Docking, and Bioactivity
    Authors: M. Yadav, R. Rao, S. Kumar, A. Kapoor
    Journal: ChemistrySelect, Vol. 8 (45), 2023
  • Development of 2-Dimensional and 3-Dimensional QSAR Models of Indazole Derivatives as TTK Inhibitors Having Anticancer Potential
    Authors: A.K. Mithlesh Yadav, Balasubramanian Narasimhan
    Journal: Current Chemistry Letters, Vol. 13 (1), 2023
  • Hybrid Descriptors–Conjoint Indices: A Case Study on Imidazole-Thiourea Containing Glutaminyl Cyclase Inhibitors for Design of Novel Anti-Alzheimer’s Candidates
    Authors: K. Bagri, A. Kapoor, P. Kumar, A. Kumar
    Journal: SAR and QSAR in Environmental Research, Vol. 34 (5), 2023
  • Anti-Hyperglycemic Evaluation of 2,4-Thiazolidinedione and Rhodanine Derivatives
    Authors: A. Kapoor, N. Khare
    Journal: Der Pharma Chemica, Vol. 8 (12), 2016
  • A Review on the Drug Delivery Strategies for Parasitic Infections: Scope and Assertion
    Authors: M. Bhatia, S. Kumar, A. Kapoor, S. Lohan
    Journal: Drug Delivery Letters, Vol. 12 (2), 2022.